LFWD

Lifeward Ltd, formerly known as ReWalk Robotics Ltd, is a medical device company. The Company is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The Company offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The Company offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.

Wall Street analysts forecast LFWD stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for LFWD is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Lifeward Ltd revenue for the last quarter amounts to 6.20M USD, increased 1.09 % YoY.

Lifeward Ltd. EPS for the last quarter amounts to -0.20 USD, decreased -42.86 % YoY.

Lifeward Ltd (LFWD) has 80 emplpoyees as of December 15 2025.

Today LFWD has the market capitalization of 12.38M USD.